Global Subcutaneous Drug Delivery Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029

“Global Subcutaneous Drug Delivery Devices Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global subcutaneous drug delivery devices market has been segmented on the basis of product, distribution channel, as well as regions and countries.

Request Covid - 19 Impact

Overview:

Subcutaneous drug delivery devices are specialized tools that are used to deliver a drug or therapeutic agent via a specific route of admission, in this case beneath the skin. Such devices are used as part of one or more medical treatments.

Dynamics:

The growing prevalence of cardiovascular disease and diabetes, the growth of biological drug development, and more importantly, the increasing availability of advanced minimally invasive drug delivery devices are some of the primary factors that are expected to boost the revenue growth of the global subcutaneous drug delivery devices market over the next 10 years. Moreover, the increasing incidence of diabetes is expected to be much higher in emerging economies when compared that in developed nations.

The increasing adoption of innovative products like needle-free injectors as effective substitutes to conventional drug delivery systems due to their lower treatment costs and the potential to be injured by needles are also factors that are slated to influence future market growth of this global industry.

In light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global subcutaneous drug delivery industry is no different, and this factor is expected to negatively impact on market growth in the years to come.

Nonetheless, increasing investments being made by key industry players towards future research activities to develop technologically advanced products is a factor that is anticipated to fuel the revenue growth of the global subcutaneous drug delivery devices market over the next decade.

Segmentation of the global subcutaneous drug delivery market is as follows:

In terms of product, the pen injectors segment accounted for the maximum number of revenue shares of the global subcutaneous drug delivery devices market in 2020, and is indicative of indexing a high CAGR in the years to come. This can be attributed to its lower price, easy product design, as well as the increasing social acceptance and adoption of these devices. However, the wearable injectors segment is slated to index the highest CAGR over the next 10 years.

With respect to distribution channel, the retail pharmacies segment accounted for the maximum number of revenue shares in 2020, and is slated to index considerable revenue growth over the next 10 years. The online pharmacies segment is anticipated to register the fastest rate of revenue growth due to higher number of value-added benefits being offered to its consumers.

Regional Segmentation and Analysis:

North America accounted for the highest number of revenue shares of the global subcutaneous drug delivery market in 2020, and is slated to continue doing so over the forecast period.  This can be attributed to its existing developed healthcare infrastructure, as well as the large presence of key industry players in this region. The markets in the Asia Pacific region are also slated to index considerable revenue growth in the years to come owing to the steady increase in the number of diabetic patients in this region.

Segmentation of the Global Subcutaneous Drug Delivery Devices Market:

Segmentation by Product:

• Prefilled syringes
• Pen injectors
• Auto-injectors
• Wearable injectors
• Needle-free Injectors

Segmentation by Distribution Channel:

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Segmentation by Regions:

• North America
• Europe
• APAC
• South America
• MEA

• Gerresheimer AG
• Medtronic Plc
• Ypsomed AG
• Elcam Medical Group
• Novo Nordisk A/S
• Insulet Corporation
• Becton, Dickinson and Company
• West Pharmaceutical Services Inc.
• PharmaJet Inc.
• Unilife Corporation
• Inolife Sciences Inc.